Law360, New York (May 25, 2012, 8:18 PM ET) -- Allergan Inc. and two Japanese drug makers urged a Delaware federal court Thursday to pause Apotex Inc.'s monopolization suit over Allergan's decision to market a new formulation of Zymar until an underlying patent dispute between the companies over the eye infection medication is resolved.
In addition to asking the court to stay the suit, the defendants also lodged two separate motions to dismiss all or part of Apotex's claims, which accuse Allergan of stifling competition by trying to move the market to the new formulation of...
Allergan, Others Look To Ice Apotex Monopoly Suit
To view the full article, take a free trial now.
